NEWS & EVENTS | OSLO UNIVERSITETSSYKEHUS - HOSPITAL PAGES IN NORWEGIAN

Welcome to Johanna Olweus' group:

Immunotherapy and Antigen presentation

The immunotherapy team <i>(click to enlarge image)</i>

The immunotherapy team (click to enlarge image)

Research projects

Area 1: A novel immunotherapeutic approach to treat cancer

Area 2: Dendritic cell biology in health and disease

Informative articles about the group

Time for T - 2012

Kan immunsystemet målrettes mot kreft? - 2012

Immunceller fra friske knuser kreft – 2012

Inven2 Idépris 2011

Håp om mer målrettet behandling av leukemi – 2010

T-cellebasert immunterapi ved kreft – 2010

Cancer research project headed by Johanna Olweus presented on the front page of "Dagbladet" – 2009

Biographies

These young men and women and their families have inspired and supported our cancer research

Biographies written by their families (in Norwegian, in Word format):

Øivind Andre Grøseth

Regine Stokke

Børge Moen Stjern

Erlend Olav Bjørkøy

Print this page [6306 visits]

Situated at:

Radiumhospitalet

News & events

Kick-off seminar at Montebello on June 21st:
Focus on recruitment and career building in health research
May 24, 2013

A newly identified protein regulates cell division
May 21, 2013

The story of PCI popularized and presented in national media
May 14, 2013

Publication in Nature Genetics on testicular cancer susceptibility
May 13, 2013

Institute seminar May 8th
Gunnar Kvalheim
May 6, 2013

More news

Latest articles

Immunotherapy and antigen presentation group

Dollner R, Taraldsrud E, Iversen K, Osnes T, Kristensen B, Kramer MF (2013)
Non-allergic, mastocytosis-associated rhinitis
Clin Exp Allergy, 43 (4), 406-12
PubMed 23517036

Huse K, Bakkebø M, Wälchli S, Oksvold MP, Hilden VI, Forfang L, Bredahl ML, Liestøl K, Alizadeh AA, Smeland EB, Myklebust JH (2012)
Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma
PLoS One, 7 (10), e46117
PubMed 23049692

Banik D, Khan AN, Walseng E, Segal BH, Abrams SI (2012)
Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity
PLoS One, 7 (9), e45422
PubMed 23028998